Garnet Equity Capital Holdings Inc. increased its position in shares of Anterix Inc. (NASDAQ:ATEX - Free Report) by 33.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 388,829 shares of the company's stock after buying an additional 97,127 shares during the period. Anterix accounts for 1.7% of Garnet Equity Capital Holdings Inc.'s holdings, making the stock its 7th biggest holding. Garnet Equity Capital Holdings Inc. owned about 2.09% of Anterix worth $11,925,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Barclays PLC boosted its holdings in shares of Anterix by 278.2% during the 3rd quarter. Barclays PLC now owns 16,971 shares of the company's stock worth $639,000 after buying an additional 12,484 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Anterix by 188.2% during the third quarter. JPMorgan Chase & Co. now owns 33,832 shares of the company's stock worth $1,274,000 after acquiring an additional 22,092 shares in the last quarter. Inspire Investing LLC boosted its stake in Anterix by 19.4% during the fourth quarter. Inspire Investing LLC now owns 13,018 shares of the company's stock worth $399,000 after acquiring an additional 2,115 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in Anterix by 8,107.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,080 shares of the company's stock valued at $333,000 after purchasing an additional 10,945 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Anterix by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 134,400 shares of the company's stock valued at $4,122,000 after purchasing an additional 1,183 shares during the period. Institutional investors and hedge funds own 87.67% of the company's stock.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. boosted their target price on Anterix from $61.00 to $67.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th.
Check Out Our Latest Stock Report on ATEX
Anterix Price Performance
Shares of NASDAQ:ATEX traded down $0.12 during trading on Friday, reaching $29.84. 92,341 shares of the stock were exchanged, compared to its average volume of 168,285. The stock has a fifty day moving average of $34.88 and a two-hundred day moving average of $33.40. Anterix Inc. has a 1-year low of $27.37 and a 1-year high of $42.91. The firm has a market cap of $554.64 million, a price-to-earnings ratio of -18.31 and a beta of 0.94.
Anterix Company Profile
(
Free Report)
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
See Also
Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
